Author

D. G. Lalloo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 2 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

M. Mukaka· 2 shared A. Koch· 1 shared A. Westhorpe· 1 shared B. Denis· 1 shared B. Thomas· 1 shared C. G. Banda· 1 shared C. O. Omollo· 1 shared C. Venturini· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 11 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. Mukaka

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Two snakebite antivenoms have potential to reduce Eswatini's dependency upon a single, increasingly unavailable product: results of preclinical efficacy testing

S. K. Menzies, T. Litschka-Koen, R. J. Edge, J. Alsolaiss, E. Crittenden, S. R. Hall, A. Westhorpe, B. Thomas, J. Murray, N. Shongwe, S. Padidar, D. G. Lalloo, N. R. Casewell, J. Pons, R. A. Harrison

This study evaluates two antivenoms as alternatives to SAIMR Polyvalent in Eswatini, finding they are equally or more effective against the most common snake venom but less effective against others.

bioRxiv · May 16, 2022Pharmacology & Toxicology

Flow cytometry method for absolute counting and single-cell phenotyping of mycobacteria

D. A. Barr, C. O. Omollo, M. Mason, A. Koch, R. J. Wilkinson, D. G. Lalloo, G. Meintjes, V. Mizrahi, D. F. Warner, G. R. Davies

This paper develops a flow cytometry method for absolute counting and single-cell phenotyping of mycobacteria, showing it can detect cell aggregates and reveal subpopulation dynamics not captured by traditional CFU counting.

bioRxiv · May 1, 2021Microbiology

Both the inflammatory response and clinical outcome differ markedly between adults with pneumococcal and meningococcal meningitis in a high HIV-1 prevalent setting in sub-Saharan Africa

E. C. Wall, J. A. Guerra-Assuncao, B. Denis, M. Scarborough, K. Ajdukiewicz, K. Cartwright, M. Mukaka, V. S. Mlozowa, C. Venturini, T. J. Allain, D. G. Lalloo, J. S. Brown, S. B. Gordon, R. S. Heyderman

This study compares inflammatory responses and clinical outcomes between pneumococcal and meningococcal meningitis in HIV-high prevalence settings, finding worse outcomes in pneumococcal cases.

bioRxiv · Feb 3, 2019 · PreprintImmunology

Impact of efavirenz, ritonavir-boosted lopinavir and nevirapine based antiretroviral regimens on the pharmacokinetics of lumefantrine and safety of artemether-lumefantrine in falciparum-negative HIV-infected Malawian adults stabilized on antiretroviral therapy

C. G. Banda, F. K. Dzinjalamala, M. Mukaka, J. Mallewa, V. Maiden, D. J. Terlouw, D. G. Lalloo, S. Khoo, V. Mwapasa

This study evaluates how different antiretroviral therapies affect lumefantrine pharmacokinetics and the safety of artemether-lumefantrine in HIV-infected adults, finding significant variations in lumefantrine exposure and safety profiles.

bioRxiv · Jun 3, 2018Pharmacology & Toxicology